Clinical Trials in Massachusetts

Showing 4041-4060 of 15,316 trials

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

NCT03978130

RESILIENT is a phase II, multi-center, prospective, pragmatic randomized clinical trial with blinded assessment of the primary endpoint. This study aims to evaluate whether mHealth-CR improves functional capacity in older adults (age ≥65) with IHD compared with standard traditional cardiac rehabilitation care. A total of 400 eligible patients will be randomized in 3:1 manner to mHealth-CR versus usual care for assessment of primary endpoint. Enrollment will occur over approximately 42 months with an expected minimum of 3 months follow-up per participant.

Ischemic Heart Disease

NYU Langone Health400 participantsStarted Jan 2020

Worcester, Massachusetts, United States • New York, New York, United States

RECRUITINGNA26 miles

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

NCT06137807

The TricValve® Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve® Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve® Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve® Transcatheter Bicaval Valves are pre-mounted into the TricValve® Delivery System which is used for percutaneous access and delivery of the TricValve® Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.

Tricuspid RegurgitationTricuspid Valve Disease

P+F Products + Features USA Inc.50 participantsStarted Jul 2024

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +33 more locations

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Find Trials by Condition in Massachusetts

A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Promoting Shared Decision Making for Severe Aortic Stenosis

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

C-MAC Video Stylet vs. Video Endoscope

ProVIDE II Bridging Study

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections